News from ptc therapeutics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 07, 2020, 13:54 ET PTC Therapeutics Announces FDA Approval of Evrysdi™ (risdiplam) for the Treatment of Spinal Muscular Atrophy in Adults and Children 2 months and older

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the U.S. Food and Drug Administration (FDA) has approved Evrysdi™ (risdiplam), the first...


Aug 06, 2020, 08:00 ET PTC Therapeutics' Mary Frances Harmon Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine

PTC Therapeutics, Inc. (NASDAQ: PTCT) is proud to announce that its Senior Vice President of Corporate and Patient Relations, Mary Frances Harmon,...


Aug 05, 2020, 16:01 ET PTC Therapeutics Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the second quarter ending June 30, 2020....


Jul 22, 2020, 08:00 ET PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2020 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2020...


Jul 21, 2020, 09:00 ET PTC Therapeutics to Host Deep Dive Webinar on Splicing Platform

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host the second webinar in its deep dive series discussing its therapeutic...


Jul 20, 2020, 07:30 ET PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced an agreement to monetize a portion of the risdiplam royalty stream for $650 million from...


Jul 08, 2020, 08:00 ET PTC Therapeutics Announces First Patient Dosed in Phase 1 Trial for PTC857

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the first subject in the Phase 1 clinical trial evaluating PTC857 in healthy volunteers...


Jun 29, 2020, 08:00 ET PTC Therapeutics Announces CHMP Recommendation of Translarna™ (ataluren) Label Update for Non-Ambulatory Patients with Duchenne Muscular Dystrophy

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...


Jun 17, 2020, 06:30 ET PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19

PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that the U.S. Food and Drug Administration has authorized the initiation of a Phase 2/3 trial...


Jun 12, 2020, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 10, 2020 it approved non-statutory stock options to purchase an aggregate of...


Jun 12, 2020, 16:15 ET PTC Therapeutics Announces 2-year Data from Part 1 of SUNFISH and New Data from JEWELFISH Trials for Risdiplam in Patients with Spinal Muscular Atrophy

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced two-year data from Part 1 of the SUNFISH trial in children and adults with type 2 or 3 spinal...


Jun 10, 2020, 08:00 ET PTC Therapeutics Launches New "Talent Pipeline Program" to Help Students who Graduated During the 2020 COVID-19 Pandemic

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of the Talent Pipeline Program (TPP), a one-year global internship program aimed at...


Jun 01, 2020, 08:00 ET PTC Therapeutics Successfully Completes Acquisition of Censa Pharmaceuticals

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has successfully completed the acquisition of Censa Pharmaceuticals, Inc., a...


May 28, 2020, 09:00 ET PTC Therapeutics to Host First Deep Dive Webinar on Bio-e Platform

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will hold a series of virtual deep dive webinars discussing its therapeutic platforms...


May 27, 2020, 19:04 ET PTC Therapeutics, Inc. to Hold Virtual 2020 Annual Meeting of Stockholders

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that, due to the public health impact of the novel coronavirus (COVID-19) outbreak and...


May 26, 2020, 08:00 ET PTC Therapeutics to Present at the Jefferies Virtual Healthcare Conference

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the Jefferies Virtual Healthcare Conference...


May 15, 2020, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on May 11, 2020 it approved non-statutory stock options to purchase an aggregate of 50,025 ...


May 06, 2020, 16:30 ET PTC Therapeutics to Acquire Censa Pharmaceuticals

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it has entered into an agreement to acquire Censa Pharmaceuticals, Inc., a...


May 05, 2020, 08:00 ET PTC Therapeutics to Participate at Upcoming Investor Conferences

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present in a virtual format at the following conferences: 2020 BofA...


Apr 30, 2020, 16:01 ET PTC Therapeutics Reports First Quarter 2020 Financial Results and Provides a Corporate Update

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the first quarter ending March 31, 2020....


Apr 28, 2020, 01:00 ET Confirmatory Part 2 of FIREFISH Demonstrates Survival and Motor Milestones Not Seen in Natural History in Infants with Type 1 Spinal Muscular Atrophy

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced positive results from part 2 of the pivotal FIREFISH study evaluating risdiplam in infants with ...


Apr 22, 2020, 16:30 ET PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 17, 2020 it approved non-statutory stock options to purchase an aggregate of...


Apr 17, 2020, 08:00 ET PTC Therapeutics Announces New Leadership Appointments

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointments of Matthew Klein, M.D., to Chief Development Officer and Eric Pauwels to Chief ...


Apr 16, 2020, 08:00 ET PTC Therapeutics to Host Conference Call to Discuss First Quarter 2020 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2020 financial ...


Apr 07, 2020, 16:05 ET PTC Announces Regulatory Update on Risdiplam for Spinal Muscular Atrophy (SMA)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee...